Quantum Genesis AI OTC Markets Caveat Emptor Designation Removed

Quantum Genesis AI Corp. announces the removal of the Caveat Emptor designation by OTC Markets Group, signaling improved transparency and compliance.

June 1, 2026
Quantum Genesis AI OTC Markets Caveat Emptor Designation Removed

Quantum Genesis AI Corp. (OTC: QGAI) announced today that the Caveat Emptor designation previously applied to its securities by OTC Markets Group has been removed. The company expressed appreciation for the opportunity to engage with OTC Markets throughout the review process and acknowledged the professionalism and assistance provided.

Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI, stated, 'We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation. Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement.'

The removal of the Caveat Emptor designation is significant for Quantum Genesis AI as it signals that the company has addressed the concerns that led to the designation. Caveat Emptor is a label applied by OTC Markets to warn investors that there may be public interest concerns, such as a lack of current information or potential fraudulent activities. Its removal indicates that the company has provided sufficient information and demonstrated compliance with disclosure requirements.

This development could restore investor confidence and potentially improve liquidity for QGAI shares. The company continues to advance its strategic initiatives in artificial intelligence, computational modeling, and scientific innovation, while maintaining a commitment to responsible corporate governance and public company compliance.

Quantum Genesis AI intends to continue providing timely updates regarding its business activities and corporate developments through its public disclosures and shareholder communications. For more information, visit the company's website at www.qgaicorp.com and its profile on OTC Markets at www.otcmarkets.com/stock/QGAI.

The company is focused on advancing next-generation technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. Its strategy includes leveraging advanced data-driven tools to support research, discovery, and technology development across emerging sectors.

Quantum Genesis AI OTC Markets Caveat Emptor Designation Removed | Boostify